Balanced news tone
News Sentiment
INCY sentiment intelligence
Incyte Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
56
Balanced news tone
58 relevant articles
Price is moving more forcefully than the current news tone suggests.
75/100 classification confidence.
directly relevant articles
high-authority source matches
-9.5% over one week, +1.1% over four weeks, trend inactive, and materially above fair value.
Truist raises Incyte stock price target to $105 on VWD outlook
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
75/100 classification
One-week reaction
-9.5%
Price reacting lower
Trend fit
Trend inactive
1.1% over four weeks
Fair value
34.7%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
22
Neutral
29
Negative
7
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
StockStory
Direct company coverage
Why Incyte (INCY) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 16:15
- Source
- StockStory
TradingView
Direct company coverage
Incyte to Buy Vega Therapeutics in Hematology Deal Worth Up to $2B
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 09 Jun 2026 07:00
- Source
- TradingView
ChartMill
Direct company coverage
Incyte Corp (NASDAQ:INCY) Screens as a Deep Value Opportunity with Strong Profitability
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- ChartMill
Quiver Quantitative
Direct company coverage
Incyte shares rise 6.2% amid renewed optimism around late-stage pipeline and recent partnership update
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 03 Jun 2026 07:00
- Source
- Quiver Quantitative
DirectorsTalk Interviews
Direct company coverage
Incyte Corporation (INCY) Stock Analysis: Exploring a Strong 11.6% Potential Upside for Investors
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- DirectorsTalk Interviews
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Impressive Earnings May Not Tell The Whole Story For Incyte (NASDAQ:INCY)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 May 2026 07:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Jakafi XR Approval Tests Incyte Valuation As Growth Outlook Softens
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 06 May 2026 07:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Is It Too Late To Consider Incyte (INCY) After A 55% One Year Rally?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 May 2026 07:00
- Source
- simplywall.st
Stock Titan
Direct company coverage
One pill a day: FDA approves Incyte's Jakafi XR for 3 conditions
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Stock Titan
simplywall.st
Direct company coverage
Incyte (INCY) Margin Reset To 26.7% Tests Bullish Profit Durability Narratives
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 29 Apr 2026 07:00
- Source
- simplywall.st
ChartMill
Direct company coverage
Incyte (NASDAQ:INCY) Beats Q1 Estimates and Unveils Robust Pipeline Catalysts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 28 Apr 2026 07:00
- Source
- ChartMill
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
TradingView
Direct company coverage
Incyte Gears Up to Report Q1 Earnings: What Can Investors Expect?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Apr 2026 07:00
- Source
- TradingView
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
lwvtexas.org
Direct company coverage
Incyte (INCY) Stock Analysis | Incyte Corp Posts 8.5% EPS Miss Vs Consensus Views - Banking Earnings Report
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 16 Apr 2026 07:00
- Source
- lwvtexas.org
lwvtexas.org
Direct company coverage
INCY Stock Analysis: Incyte Corp biotech stock rises 1.73 pct near 96 dollar mark
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Apr 2026 07:00
- Source
- lwvtexas.org
Market source
Direct company coverage
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Mar 2026 07:00
- Source
- Market source
TIKR.com
Direct company coverage
Incyte Shares Drop 8% Post-Earnings: Analysts Target $104 Amid 2026 Guidance Concerns
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 11 Feb 2026 08:00
- Source
- TIKR.com
Market source
Direct company coverage
Why Incyte (INCY) Stock Is Nosediving
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Feb 2026 08:00
- Source
- Market source
TradingView
Direct company coverage
INCY Stock Price and Chart — NASDAQ:INCY
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jan 2026 08:00
- Source
- TradingView
StockStory
Direct company coverage
Incyte (INCY) Stock Is Up, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jan 2026 08:00
- Source
- StockStory
simplywall.st
Industry context
With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 09 Dec 2025 08:00
- Source
- simplywall.st
Investing News Network
Direct company coverage
Incyte and Winnie Harlow Join Forces to Share Her Personal Vitiligo Story and Spark Conversation and Understanding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Dec 2025 08:00
- Source
- Investing News Network
simplywall.st
Direct company coverage
Results: Incyte Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 31 Oct 2025 07:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Incyte Corporation's (NASDAQ:INCY) Price Is Right But Growth Is Lacking After Shares Rocket 26%
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Aug 2025 07:00
- Source
- simplywall.st